Johnson & Johnson
Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements
Johnson & Johnson (NYSE: JNJ) is navigating a critical juncture in its protracted legal battle over talc-based baby powder. The healthcare behemoth has announced a tentative $700 million settlement with 43 U.S. states and the District of Columbia to resolve allegations of deceptive marketing practices. Simultaneously, the company has